Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

Rationale: Spinal cord infarction (SCI) accounted for only 1% to 2% of all ischemic strokes and 5% to 8% of acute myelopathies. Magnetic resonance imaging (MRI) play a role in the exclusion of non-ischemic etiology, but the diagnostic accuracy of this procedure may be low in confirming the diagnosis, even when the vast marrow lesions are present. Indeed, changes in MRI T2 can develop from hours to days, thus accounting for the low sensitivity in the setting of hyperacute (ie, within 6 hours of onset of symptoms).

For this reason, SCI remains a clinical diagnosis. Although the diagnostic work-up wide, up to 20% to 40% of cases of SCI are classified as cryptogenic. Here, we describe a case of cryptogenic longitudinally extensive transverse myelopathy due to SCI, with negative MRI and diffusion-weighted imaging at 9 hours after the initial symptoms.

patient concerns: A 51 years old woman presented to our emergency department with severe acute abdominal pain, nausea, vomiting, sudden-onset bilateral leg weakness with diffuse sensory loss and paraesthesia in the trunk and legs.
Diagnosis: On neurological examination, she showed severe paraparesis and sensory level D6. A spinal cord 3T MRI with gadolinium performed at 9 hours after onset of symptoms does not detect changes in the spinal cord. Due to the persistence of a suggestive clinical picture of myelopathy acute, 3T MRI of the spine was repeated after 72 hours showed hyperintense “pencil-like” signals mainly involving the gray matter of T1 to T6 at T2 sequence, slightly hypointense on T1 and the diffusion limited.

Intervention: Patients were given a salicylic acid (100 mg / d), a low molecular weight heparin prophylaxis, and start neuromotor rehabilitation.
Results: Two months later, a follow-up neurological examination revealed severe spastic paraparesis, there is a clear sensory level and sphincter control was poor with bladder distension.

Lesson: Apart from a relatively low frequency in the general population, SCI should be suspected in any patient presenting with symptoms of acute and progressive myelopathic, even without the presence of vascular risk factors. Thus, the clinical presentation consistent with a potential vascular syndromes involving the spinal cord MRI override initially negative and should not delay the timely and proper management.

Cultivated tomato (Solanum lycopersicum L.) suffer severe bottlenecks during domestication of the strain: Implications of the chloroplast genome

In a variety of plants, genetic bottlenecks occur through domestication can limit plant resistance to biotic and abiotic stresses. In this study, we investigated the nucleotide diversity in tomato chloroplast genome by sequencing seven plastomes of cultivated accessions from the Campania region (southern Italy) and two wild species among the closest (Solanum pimpinellifolium) and most distantly related (S. neorickii) tomato species cultivated. comparative analysis between the chloroplast genome sequenced in this work and are available at GenBank allowed to evaluate the variability plastomes and defining phylogenetic relationships.

A dramatic reduction in genetic diversity detected in cultivated tomatoes, however, de novo mutations some, still distinguishable tomatoes cultivated from the nearest wild relative S. pimpinellifolium, which are detected and can potentially be used as a diagnostic marker. phylogenetic analysis confirms that S. pimpinellifolium is the closest ancestor of all cultivated tomatoes. Local accession all gathered together and strictly related to other cultivated tomato (S. lycopersicum group). Noteworthy, S. lycopersicum var. cerasiforme resulting in a mix of both cultivated and wild tomato genotypes for one of the two accessions analyzed teem with tomatoes cultivated, whereas others with S. pimpinellifolium.

 Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature

The whole exome Analysis of Congenital Muscular Dystrophy and congenital myopathy patients from India Unveils Wide Spectrum of Known and Novel Mutation

Background: Congenital muscular dystrophy (CMD) and the congenital myopathies (CM) is a clinically heterogeneous group of genetic and degenerative primary muscle disorder with onset at birth or during infancy. Due to the extensive heterogeneity, clinical examination and analysis of protein-based often fail to identify the genetic causes of this disease.

Methods: Whole exome sequencing (WES) conducted to identify genetic mutations and diagnose pathogens cohort of 36 hard-to-diagnose cases CM CMD and Indian origin, using a variant of the call and a rigorous filtration process variants. Furthermore, in silico modeling and molecular dynamics (MD) study conducted for a number of novels and missense variants.

Results: A total of 33 and 21 rare and damaging mutations identified in 28 genes were previously reported in CMD and CM based OMIM, ClinVar and Orphanet, respectively. We can accurately diagnose 54% of patients (n = 12/22) in the group of CMD and 35% of patients (n = 5/14) in the group CM. Furthermore, the study for the MD is located in LMNA mutations, lama2 and RYR1, indicating that the wild type of protein is more stable than their mutant counterparts, implying a potential mechanism of pathogenesis.

NATtrol Staphylococcus aureus (MSSA); -mecA, External Run Control, Low (6X1mL)

NATSAU(MSSA)-ERCL 6X1mL
EUR 360

NATtrol Zika Virus (PRVABC59), External Run Control, Low (6 x 1.0 mL)

NATZIKV(PRV)-ERCL 6 x 1.0 mL
EUR 350

NATtrol Mycoplasma pneumoniae M129, External Run Control, Low (6 X 1 mL)

NATMPN(M129)-ERCL 6 X 1 mL
EUR 360

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Low (6 X 1 mL)

NATNG-ERCL 6 X 1 mL
EUR 360

NATtrol Staphylococcus aureus (MRSA) External Run Control, Low (6 X 1 mL)

NATSAU(MRSA)-ERCL 6 X 1 mL
EUR 360

NATtrol Clostridium difficile NAP1, External Run Control, Low (6 X 1 mL)

NATCDI(NAP1)-ERCL 6 X 1 mL
EUR 438

NATtrol HIV Type 1 Strain: IIIB External Run Control, Low (6 X 1 mL)

NATHIV1-ERCL 6 X 1 mL
EUR 360

NATtrol Cytomegalovirus (CMV) Strain: AD-169 External Run Control, Low (6X1 mL)

NATCMV-ERCL 6X1 mL
EUR 360

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Low (6 X 1 mL)

NATECO(933)-ERCL 6 X 1 mL
EUR 360

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Low (6 X 1 mL)

NATCT(434)-ERCL 6 X 1 mL
EUR 360

NATtrol Chlamydia trachomatis serotype D, External Run Control, Low (6 X 1 mL)

NATCT(D-UW3)-ERCL 6 X 1 mL
EUR 360

NATtrol BK Virus External Run Control, Medium (6 X 1 mL)

NATBK-ERCM 6 X 1 mL
EUR 438

NATtrol Mycoplasma genitalium External Run Control (6 x 0.25mL)

NATMGN-ERC 6 x 0.25mL
EUR 301

NATtrol Zika Virus, External Run Control, Medium (6 x 1 mL)

NATZIKV-ERCM 6 x 1 mL
EUR 425

NATtrol Epstein Barr Virus (EBV) Strain: B95-8, External Run Control-Low (6X1mL)

NATEBV-ERCL 6X1mL
EUR 349

NATtrol P. jirovecii Recombinant External Run Control (6 x 0.5mL)

NATPJI-ERC 6 x 0.5mL
EUR 365

NATtrol Flu/RSV/SARS-CoV-2 External Run Control (6 x 0.5mL)

NATFRC-ERC -
EUR 278

NATtrol Zika Virus (PRVABC59), External Run Control, Medium (6 x 1.0mL)

NATZIKV(PRV)-ERCM 6 x 1.0mL
EUR 425

NATtrol Staphylococcus aureus (MSSA); -mecA,External Run Control, Medium (6X1mL)

NATSAU(MSSA)-ERCM 6X1mL
EUR 438

NATtrol Cytomegalovirus (CMV) Strain:AD-169 External Run Control, Medium (6X1mL)

NATCMV-ERCM 6X1mL
EUR 438

NATtrol Chlamydia trachomatis LGV II 434, External Run Control, Medium (6X1mL)

NATCT(434)-ERCM 6X1mL
EUR 438

NATtrol Chlamydia trachomatis serotype D, External Run Control, Medium (6X1mL)

NATCT(D-UW3)-ERCM 6X1mL
EUR 438

NATtrol HIV Type 1 Strain: IIIB External Run Control, Medium (6 X 1 mL)

NATHIV1-ERCM 6 X 1 mL
EUR 438

NATtrol Mycoplasma pneumoniae M129, External Run Control, Medium (6 X 1 mL)

NATMPN(M129)-ERCM 6 X 1 mL
EUR 438

NATtrol Neisseria gonorrhoeae Z017, External Run Control, Medium (6 X 1 mL)

NATNG-ERCM 6 X 1 mL
EUR 438

NATtrol Staphylococcus aureus (MRSA) External Run Control, Medium (6 X 1 mL)

NATSAU(MRSA)-ERCM 6 X 1 mL
EUR 438

NATtrol Clostridium difficile NAP1, External Run Control, Medium (6 X 1 mL)

NATCDI(NAP1)-ERCM 6 X 1 mL
EUR 557

NATtrol Epstein Barr Virus (EBV) Strain:B95-8,External Run Control-Medium(6X1mL)

NATEBV-ERCM 6X1mL
EUR 425

NATtrol Escherichia coli 0157:H7;EDL933, External Run Control, Medium (6 X 1 mL)

NATECO(933)-ERCM 6 X 1 mL
EUR 438

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL)

NATSARS(COV2)-ERC 6 x 0.5 mL
EUR 416

NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 1.0 mL)

NATSARS(COV2)-ERC1 6 x 1.0 mL
EUR 568

FOB Rapid Test External Control Kit

C2011 each
EUR 560

INFLUENZA B RNA CONTROL

MBS180030-INQUIRE INQUIRE Ask for price

Dengue Ag Rapid Test External Control Kit

C0063 each
EUR 560

H. pylori Ag Rapid Test External Control Kit

C0192 each
EUR 560

COVID-19 Ag Rapid Test External Control Kit

C0182 each
EUR 520

Influenza B Virus IgA Control Serum

C1232A 3 mL
EUR 105

Influenza B Virus IgG Control Serum

C1232G 3 mL
EUR 105

Influenza B Virus IgM Control Serum

C1232M 3 mL
EUR 105

NATtrol Influenza A/B Positive Control (6 x 0.5mL)

NATFLUAB-6C 6 x 0.5mL
EUR 211

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

MDZ046 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Influenza A/B Positive Control (6 X 0.5 mL)

NATFLUA/B-6MC 6 X 0.5 mL
EUR 227

NATtrol Influenza A/B  Positive Control (6 X 0.5 mL)

NATFLUAB-6C-IVD 6 X 0.5 mL
EUR 231

Influenza A Virus IgA Control Serum

C1231A 3 mL
EUR 105

Influenza A Virus IgG Control Serum

C1231G 3 mL
EUR 105

Influenza A Virus IgM Control Serum

C1231M 3 mL
EUR 105

Purified Influenza A Neuraminidase (H1N1-NA) protein control for western blot

H1N1NA11-C 100 ul
EUR 343.2

NATtrol Influenza Negative Control (6 X 0.5 mL)

NATCXVA9-6MC 6 X 0.5 mL
EUR 220

NATtrol Influenza/RSV Negative Control (6 x 0.5mL)

NATCXVA9-6C 6 x 0.5mL
EUR 220

NATtrol Influenza/RSV Positive Control (6 x 0.25mL)

NATFLURSV-6L 6 x 0.25mL
EUR 272

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

MDZ045 6 X 0.5 mL
EUR 272.16
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Influenza/RSV Positive Control (6 x 0.5 mL)

NATFLURSV-6C 6 x 0.5 mL
EUR 221

NATtrol Influenza/RSV Negative Control (6 X 0.5 mL)

NATCXVA9-6C-IVD 6 X 0.5 mL
EUR 240

Influenza Rapid Test Control Pack (3 X 1.5mL)

KZMC033 3 X 1.5mL
EUR 59

Influenza A virus HA Control/blocking peptide

AB-23091-P 100ug
EUR 196.8

NATtrol Influenza A H1N1 Positive Control (6 X 0.5 mL)

NATFLUAH1N1-6MC 6 X 0.5 mL
EUR 227

Influenza A H5N1 Hemagglutinin, (IN) Control Peptide

MBS659985-005mg 0.05mg
EUR 790

Influenza A H5N1 Hemagglutinin, (IN) Control Peptide

MBS659985-5x005mg 5x0.05mg
EUR 3395

Influenza A H5N8 HEK293 Cell Lysate (WB positive control)

MBS8116013-03mg 0.3mg
EUR 280

Influenza A H5N8 HEK293 Cell Lysate (WB positive control)

MBS8116013-5x03mg 5x0.3mg
EUR 1205

Influenza A H5N8 HEK293 Cell Lysate (WB positive control)

MBS8116019-03mg 0.3mg
EUR 280

Influenza A H5N8 HEK293 Cell Lysate (WB positive control)

MBS8116019-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/4/2006) Nucleo Insect Cell Lysate (WB positive control)

MBS8116049-03mg 0.3mg
EUR 280

Influenza B (B/Florida/4/2006) Nucleo Insect Cell Lysate (WB positive control)

MBS8116049-5x03mg 5x0.3mg
EUR 1205

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide

MBS658813-005mg 0.05mg
EUR 700

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN), Control Peptide

MBS658813-5x005mg 5x0.05mg
EUR 2990

Influenza A, Avian, H5N1, Neuraminidase (CT) (NA) Control Peptide

MBS655299-005mg 0.05mg
EUR 695

Influenza A, Avian, H5N1, Neuraminidase (CT) (NA) Control Peptide

MBS655299-5x005mg 5x0.05mg
EUR 2975

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide

MBS633819-005mg 0.05mg
EUR 880

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide

MBS633819-5x005mg 5x0.05mg
EUR 3820

Influenza A H5N1, Nonstructural Protein 1 (NS1), Control Peptide

MBS658284-005mg 0.05mg
EUR 695

Influenza A H5N1, Nonstructural Protein 1 (NS1), Control Peptide

MBS658284-5x005mg 5x0.05mg
EUR 2975

Recombinant Purified Hemagglutinin Influenza A Virus (H11N2; A/duck/Yangzhou/906/2002) protein control for Western

H11N2-01-C 100 ul
EUR 343.2

Influenza B (B/Utah/02/2012) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116065-03mg 0.3mg
EUR 280

Influenza B (B/Utah/02/2012) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116065-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Oita/15/1992) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116237-03mg 0.3mg
EUR 280

Influenza B (B/Oita/15/1992) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116237-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Victoria/02/1987) Hemagglutinin Insect Cell Lysate (WB positive control)

MBS8115919-03mg 0.3mg
EUR 280

Influenza B (B/Victoria/02/1987) Hemagglutinin Insect Cell Lysate (WB positive control)

MBS8115919-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Maryland/1959) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116235-03mg 0.3mg
EUR 280

Influenza B (B/Maryland/1959) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116235-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Phuket/3073/2013) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119647-03mg 0.3mg
EUR 280

Influenza B (B/Phuket/3073/2013) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119647-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Ohio/01/2005) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116062-03mg 0.3mg
EUR 280

Influenza B (B/Ohio/01/2005) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116062-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Utah/02/2012) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116066-03mg 0.3mg
EUR 280

Influenza B (B/Utah/02/2012) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116066-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116108-03mg 0.3mg
EUR 280

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116108-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Sydney/3/2002) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116238-03mg 0.3mg
EUR 280

Influenza B (B/Sydney/3/2002) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116238-5x03mg 5x0.3mg
EUR 1205

Influenza A virus (H5N1) matrix protein 2 Control/blocking peptide

M2E15-P 100 ug
EUR 196.8

Influenza A virus (H1N1) matrix protein 2 Control/blocking peptide

M2E16-P 100 ug
EUR 196.8

Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide

M2E17-P 100 ug
EUR 196.8

Influenza B (B/Colorado/06/2017) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119894-INQUIRE INQUIRE Ask for price

Influenza B (B/Brisbane/60/2008) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119895-INQUIRE INQUIRE Ask for price

Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115772-03mg 0.3mg
EUR 280

Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115772-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8115774-03mg 0.3mg
EUR 280

Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8115774-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Yamagata/16/1988) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115911-03mg 0.3mg
EUR 280

Influenza B (B/Yamagata/16/1988) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115911-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/07/2004) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116044-03mg 0.3mg
EUR 280

Influenza B (B/Florida/07/2004) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116044-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116109-03mg 0.3mg
EUR 280

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116109-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA0 Insect Cell Lysate (WB positive control)

MBS8116110-03mg 0.3mg
EUR 280

Influenza B (B/PHUKET/3073/2013) Hemagglutinin/HA0 Insect Cell Lysate (WB positive control)

MBS8116110-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Colorado/06/2017) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116163-03mg 0.3mg
EUR 280

Influenza B (B/Colorado/06/2017) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116163-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/4/2006) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114346-03mg 0.3mg
EUR 280

Influenza B (B/Florida/4/2006) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114346-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Malaysia/2506/2004) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8114730-03mg 0.3mg
EUR 280

Influenza B (B/Malaysia/2506/2004) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8114730-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Malaysia/2506/2004) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114732-03mg 0.3mg
EUR 280

Influenza B (B/Malaysia/2506/2004) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114732-5x03mg 5x0.3mg
EUR 1205

Influenza A H5N1 (Avian) Nonstructural Protein 2 (NS2), Control Peptide

MBS633841-005mg 0.05mg
EUR 695

Influenza A H5N1 (Avian) Nonstructural Protein 2 (NS2), Control Peptide

MBS633841-5x005mg 5x0.05mg
EUR 2975

Influenza B (B/Ann Arbor/1/1986) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116236-03mg 0.3mg
EUR 280

Influenza B (B/Ann Arbor/1/1986) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116236-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Lee/1940) Neuraminidase/NA (His Tag) HEK293 Cell Lysate (WB positive control)

MBS8116274-03mg 0.3mg
EUR 280

Influenza B (B/Lee/1940) Neuraminidase/NA (His Tag) HEK293 Cell Lysate (WB positive control)

MBS8116274-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Massachusetts/03/2010) Hemagglutinin HEK293 Cell Lysate (WB positive control)

MBS8115954-03mg 0.3mg
EUR 280

Influenza B (B/Massachusetts/03/2010) Hemagglutinin HEK293 Cell Lysate (WB positive control)

MBS8115954-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Washington/02/2019) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119750-03mg 0.3mg
EUR 280

Influenza B (B/Washington/02/2019) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119750-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Washington/02/2019) Neuraminidase/NA Insect Cell Lysate (WB positive control)

MBS8119902-INQUIRE INQUIRE Ask for price

Influenza B (B/Yamagata/16/1988) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8115912-03mg 0.3mg
EUR 280

Influenza B (B/Yamagata/16/1988) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8115912-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116043-03mg 0.3mg
EUR 280

Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116043-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Wisconsin/01/2012) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116064-03mg 0.3mg
EUR 280

Influenza B (B/Wisconsin/01/2012) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116064-5x03mg 5x0.3mg
EUR 1205

Influenza A, Avian, IN H5N1, Neuraminidase (NA) Control Peptide (Bird Flu)

MBS655176-005mg 0.05mg
EUR 395

Influenza A, Avian, IN H5N1, Neuraminidase (NA) Control Peptide (Bird Flu)

MBS655176-5x005mg 5x0.05mg
EUR 1630

Influenza A, Avian, H5N1, CT, Neuraminidase (NA) Control Peptide (Bird Flu)

MBS655238-005mg 0.05mg
EUR 395

Influenza A, Avian, H5N1, CT, Neuraminidase (NA) Control Peptide (Bird Flu)

MBS655238-5x005mg 5x0.05mg
EUR 1630

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu)

MBS658994-005mg 0.05mg
EUR 395

Influenza A, Avian, H5N1, Hemagglutinin (HA) (NT) Control Peptide (Bird Flu)

MBS658994-5x005mg 5x0.05mg
EUR 1630

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu)

MBS659545-005mg 0.05mg
EUR 395

Influenza A, Avian, H5N1, Hemagglutinin (HA) (IN) Control Peptide (Bird Flu)

MBS659545-5x005mg 5x0.05mg
EUR 1630

Influenza B (B/Hong Kong/05/1972) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116063-03mg 0.3mg
EUR 280

Influenza B (B/Hong Kong/05/1972) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116063-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115953-03mg 0.3mg
EUR 280

Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8115953-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA0 Insect Cell Lysate (WB positive control)

MBS8115955-03mg 0.3mg
EUR 280

Influenza B (B/Massachusetts/03/2010) Hemagglutinin/HA0 Insect Cell Lysate (WB positive control)

MBS8115955-5x03mg 5x0.3mg
EUR 1205

Influenza A H2N2 Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8115797-03mg 0.3mg
EUR 280

Influenza A H2N2 Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8115797-5x03mg 5x0.3mg
EUR 1205

Influenza A H1N1 Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8114643-03mg 0.3mg
EUR 280

Influenza A H1N1 Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8114643-5x03mg 5x0.3mg
EUR 1205

Recombinant Purified Hemagglutinin Influenza A Virus H1N1 H1 (H1N1) (A/New Caledonia/20/99) protein control for Western

H1N1-01-C 100 ul
EUR 343.2

Influenza B virus (B/Victoria/504/2000) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116023-03mg 0.3mg
EUR 280

Influenza B virus (B/Victoria/504/2000) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116023-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8115773-03mg 0.3mg
EUR 280

Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8115773-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Victoria/02/1987) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8115920-03mg 0.3mg
EUR 280

Influenza B (B/Victoria/02/1987) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8115920-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Hong Kong/CUHK50947/2004) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116239-03mg 0.3mg
EUR 280

Influenza B (B/Hong Kong/CUHK50947/2004) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8116239-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/4/2006) Hemagglutinin (HA2 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114343-03mg 0.3mg
EUR 280

Influenza B (B/Florida/4/2006) Hemagglutinin (HA2 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114343-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/4/2006) Hemagglutinin (HA2 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114344-03mg 0.3mg
EUR 280

Influenza B (B/Florida/4/2006) Hemagglutinin (HA2 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114344-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Florida/4/2006) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114345-03mg 0.3mg
EUR 280

Influenza B (B/Florida/4/2006) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114345-5x03mg 5x0.3mg
EUR 1205

Influenza B (B/Malaysia/2506/2004) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114731-03mg 0.3mg
EUR 280

Influenza B (B/Malaysia/2506/2004) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control)

MBS8114731-5x03mg 5x0.3mg
EUR 1205

Human anti-H. Influenzae B (Hib-PRP) IgG negative control serum

980-101-HNC 1 ml
EUR 196.8

Human anti-H. Influenzae B (Hib-PRP) IgG positive control serum

980-101-HPC 1 ml
EUR 270

Influenza virus B (B/PHUKET/3073/2013) Neuraminidase/NA Insect Cells Cell Lysate (WB positive control)

MBS8116112-03mg 0.3mg
EUR 280

Influenza virus B (B/PHUKET/3073/2013) Neuraminidase/NA Insect Cells Cell Lysate (WB positive control)

MBS8116112-5x03mg 5x0.3mg
EUR 1205

Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control)

MBS8115775-03mg 0.3mg
EUR 280

Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control)

MBS8115775-5x03mg 5x0.3mg
EUR 1205

Influenza A H1N1 (A/Fort Monmouth/1/1947) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116115-03mg 0.3mg
EUR 280

Influenza A H1N1 (A/Fort Monmouth/1/1947) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8116115-5x03mg 5x0.3mg
EUR 1205

Control for ER, 4 cases (1.5mm) HumanBreastBreastIHC control

ERC081 1
EUR 50

Control for PR, 3 cases (1.5mm) HumanBreastBreastIHC control

PRC061 1
EUR 50

Control for HER2, 4 cases (1.5mm) HumanBreastBreastIHC control

HRC081 1
EUR 50

Influenza A H1N1 (A/Fort Monmouth/1/1947) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116116-03mg 0.3mg
EUR 280

Influenza A H1N1 (A/Fort Monmouth/1/1947) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control)

MBS8116116-5x03mg 5x0.3mg
EUR 1205

Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide

M2E11-P 100 ug
EUR 196.8

Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control

TYROSIN081 1.5mm
EUR 50

Conclusions: The findings WES has led us to identify new variants were reported as well as for the first time in India CMD and CM patients. This allows us to achieve an accurate genetic diagnosis that are otherwise difficult using conventional diagnostic tools. Transferring WES findings for clinical practice will help the clinical care of patients affected guided and informed genetic counseling.

Related Posts

Leave a Reply

Your email address will not be published.